Skip to main content
SpringerLink
Log in

Primary plasma cell leukemia followed by testicular plasmacytoma

  • Case Report
  • Published:
International Journal of Hematology Aims and scope Submit manuscript

Abstract

Plasma cell leukemia (PCL) is a highly aggressive plasma cell disease characterized by a poor prognosis and a low response rate to conventional therapy. Herein, we describe a 69-year-old patient with primary PCL, developing testicular disease while in complete hematological remission, following by muscle involvement and peritoneal dissemination.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Kyle RA, Maldonado JE, Bayrd ED. Plasma cell leukemia. Report on 17 cases. Arch Intern Med. 1974;133:813.

    Article  CAS  PubMed  Google Scholar 

  2. International Myeloma Working Group. Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121:749–57.

    Article  Google Scholar 

  3. Jimenez-Zepeda VH, Dominguez-Martinez VJ. Plasma cell leukemia: a highly aggressive monoclonal gammopathy with a very poor prognosis. Int J Hematol. 2009;89:259–68.

    Article  PubMed  Google Scholar 

  4. Costello R, Sainty D, Bouabdallah R, Fermand JP, Delmer A, Diviné M, et al. Primary plasma cell leukemia: a report of 18 cases. Leuk Res. 2001;25(2):103–7.

    Article  CAS  PubMed  Google Scholar 

  5. Noel P, Kyle RA. Plasma cell leukemia: an evaluation of response to therapy. Am J Med. 1987;83(6):1062–8.

    Article  CAS  PubMed  Google Scholar 

  6. De Rose AF, Giglio M, Naselli A, Truini M, Carmignani G. Case report: testicular secondary localization of a multiple myeloma. Int Urol Nephrol. 2002;33(1):101–2.

    Article  PubMed  Google Scholar 

  7. Alvarez-Múgica M, Jalón Monzón A, Bulnes Vázquez V, Aguilar Andrea C, Fernández Gómez JM, González Alvarez RC, et al. Secondary testicular plasmocytoma. Arch Esp Urol. 2007;60(1):99–102.

    PubMed  Google Scholar 

  8. Turhal N, Henehan MD, Kaplan KL. Multiple myeloma: a patient with unusual features including intracranial and meningeal involvement, testicular involvement, organomegaly, and plasma cell leukemia. Am J Hematol. 1998;57(1):51–6.

    Article  CAS  PubMed  Google Scholar 

  9. Alexandrescu DT, Koulova L, Wiernik PH. Unusual cutaneous involvement during plasma cell leukaemia phase in a multiple myeloma patient after treatment with thalidomide: a case report and review of the literature. Clin Exp Dermatol. 2005;30(4):391–4.

    Article  CAS  PubMed  Google Scholar 

  10. Lewinski UH, Klein B, Gafter U, Djaldetti M. Acute plasma cell leukaemia followed by extramedullary plasmacytoma. Scand J Haematol. 1980;24(2):131–6.

    Article  CAS  PubMed  Google Scholar 

  11. Pellat-Deceunynck C, Barillé S, Jego G, Puthier D, Robillard N, Pineau D, et al. The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and a special subset of multiple myeloma. Leukemia. 1998;12:1977–82.

    Article  CAS  PubMed  Google Scholar 

  12. Walker JD, Kaczmarski RS. Survival of twenty-two months in a patient with primary plasma cell leukaemia treated with melphalan and prednisolone. Postgrad Med J. 1988;64(749):232–5.

    Article  CAS  PubMed  Google Scholar 

  13. Wellwood J, Taylor K, Wright S, Bentley M, Hill G, Phan H, et al. Relapsed plasma cell leukaemia presenting with aggressive extramedullary plasmacytomas in the meninges and testis—a missed opportunity for induction CNS prophylaxis. Leuk Lymphoma. 2002;43(4):893–6.

    Article  PubMed  Google Scholar 

  14. Finnegan DP, Kettle P, Drake M, Matthews C, Alexander HD, Popat R, et al. Bortezomib is effective in primary plasma cell leukemia. Leuk Lymphoma. 2006;47(8):1670–3.

    Article  PubMed  Google Scholar 

  15. Capalbo S, Chiefa A, Delia M, Diomede D, Liso V. Effective combination therapy of bortezomib and dexamethasone for a plasma cell leukemia patient with multiple osteolytic lesions and extramedullary involvement. Acta Oncol. 2007;46:262–4.

    Article  PubMed  Google Scholar 

  16. Al-Nawakil C, Tamburini J, Bardet V, Chapuis N, Bourry E, Roux C, et al. Bortezomib, doxorubicin and dexamethasone association is an effective option for plasma cell leukemia induction therapy. Leuk Lymphoma. 2008;49(10):2012–4.

    Article  CAS  PubMed  Google Scholar 

  17. Musto P, Rossini F, Gay F, Pitini V, Guglielmelli T, D’Arena G, et al. Efficacy and safety of bortezomib in patients with plasma cell leukemia. Cancer. 2007;109(11):2285–90.

    Article  CAS  PubMed  Google Scholar 

  18. Singh AV, Palladino MA, Lloyd GK, Potts BC, Chauhan D, Anderson KC. Pharmacodynamic and efficacy studies of the novel proteasome inhibitor NPI-0052 (marizomib) in a human plasmacytoma xenograft murine model. Br J Haematol. 2010;149(4):550–9.

    Article  CAS  PubMed  Google Scholar 

  19. Bouchard PR, Juedes MJ, Nix D, Read M. Nonclinical discovery and development of bortezomib (PS-341, VELCADER), a proteasome Inhibitor for the treatment of cancer (13-Nov-2004). In: 55th Annual Meeting of the American College of Veterinary Pathologists (ACVP) and 39th Annual Meeting of the American Society of Clinical Pathology (ASVCP), ACVP and ASVCP, editors. 2004.

Download references

Author information

Authors and Affiliations

  1. Istituto di Ematologia, Università Cattolica del Sacro Cuore, Largo Francesco Vito, 1, 00168, Rome, Italy

    Caterina Giovanna Valentini, Valentina Bozzoli, Luana Fianchi, Maria Teresa Voso, Gianluigi Di Paolantonio, Marianna Criscuolo, Giuseppe Leone & Livio Pagano

  2. Istituto di Anatomia Patologica, Università Cattolica del Sacro Cuore, Rome, Italy

    Luigi Maria Larocca

Authors
  1. Caterina Giovanna Valentini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Valentina Bozzoli
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Luana Fianchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maria Teresa Voso
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Gianluigi Di Paolantonio
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Marianna Criscuolo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Giuseppe Leone
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Luigi Maria Larocca
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Livio Pagano
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Caterina Giovanna Valentini.

About this article

Cite this article

Valentini, C.G., Bozzoli, V., Fianchi, L. et al. Primary plasma cell leukemia followed by testicular plasmacytoma. Int J Hematol 93, 224–227 (2011). https://doi.org/10.1007/s12185-010-0745-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12185-010-0745-z

Keywords

Search

Navigation